+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levofloxacin"

Levofloxacin Market Report 2025 - Product Thumbnail Image

Levofloxacin Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Inhaled Antibiotics Market Report 2025 - Product Thumbnail Image

Inhaled Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Uncomplicated Urinary Tract Infection Treatment Market Report 2024 - Product Thumbnail Image

Uncomplicated Urinary Tract Infection Treatment Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
From
Bronchitis - Pipeline Insight, 2024 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Levofloxacin is a broad-spectrum antibiotic used to treat a variety of bacterial infections. It belongs to the class of antibiotics known as fluoroquinolones, which are used to treat a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. Levofloxacin is effective against both Gram-positive and Gram-negative bacteria, making it a useful tool in the treatment of many bacterial infections. It is also used to treat certain types of pneumonia, as well as some sexually transmitted diseases. Levofloxacin is available in both oral and intravenous forms, and is generally well tolerated with few side effects. It is often prescribed as a first-line treatment for bacterial infections, as it is generally more effective than other antibiotics. The market for Levofloxacin is highly competitive, with many companies offering the drug in various forms. Some of the major players in the market include Pfizer, Merck, Johnson & Johnson, Bayer, and Sanofi. Show Less Read more